Transforming global genetic data into medical decisions

Our goal is the rapid medical diagnosis of inherited diseases, provided at the earliest possible moment as we turn analytical information into actionable results for physicians, patients and pharmaceutical partners.

Our commitment to the global medical community is an early and precise diagnosis for continuous improvement of therapeutic options for each individual patient.

 

Our Latest Scientific News


Customer Feedback

At CENTOGENE we are constantly seeking to improve our products and services. Therefore, your opinion is very important to us. Please take a few minutes to answer four brief questions. We highly appreciate it! 

Give feedback

Subscribe to our Newsletter

Testimonials

Dear Prof. Rolfs, ...

... we inform you of the enormous success of the OpenMinds gala event held on Feb 22, 2018 in Beirut. The support of Centogene was very much heart felt and appreciated. Read more...

Beirut, March 2018

Dear colleagues, ...

... the world's best laboratory Centogene!

Ukraine, December 2016

Congratulation ...

... for this success. The secret key of such achievement is the continuous unlimited help, collaboration, dedication and hard work from Centogene team. Special thanks to Daniel and Rami. Looking forward for more publications togother in the near future.

Riyadh, November 2016

I am an experienced neurogeneticist ...

and moved back to Lebanon from the US wanting to make a difference in the diagnosis, care and prevention of recurring neurogenetic disorders in the Lebanese. Alas, I was only partially successful, ... Read more

Lebanon, January 2016

Thank you ...

... very much for your unlimited help and support.

Saudi-Arabia, December 2015


ROSTOCK, GERMANY, May 9, 2018 – CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and...

Read more

Rostock, Germany, May 4, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today...

Read more

ROSTOCK, GERMANY, May 2, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners,...

Read more

ROSTOCK, GERMANY, April 27, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners,...

Read more

ROSTOCK, GERMANY, April 10, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners,...

Read more

Dr. Anton Mamin has recently started his new position being responsible for strategic guidance to clinical trial growth and worldwide patient recruitment for...

Read more

CENTOGENE´s Chief Financial Officer, Richard Stoffelen, is scheduled to present at the upcoming Cowen and Company 38th Annual Health Care Conference in Boston...

Read more

There are more than 7,000 rare diseases where about 80% are hereditary. About 30 million Americans are living with a rare disease today; worldwide more than 350...

Read more

We mark Rare Disease Day 2018 with continued commitment to reduce time to diagnosis of rare diseases.

CENTOGENE has published a scientific paper that further...

Read more